跳至主要内容
临床试验/ITMCTR2000002965
ITMCTR2000002965尚未招募1 期

Study for Immune Molecular Mechanism in the Treatment of Sequelae of Pelvic Inflammatory Disease of Accumulated Damp Heat with Penyanxiao in Combination with Pelvic Perfusion

Xianyang Central Hospital0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 55(—)
性别
Female

入选标准

  • From February 20,2020 to May 31,2022, females aged 18-55 years, who were diagnosed in the hospital according to the western medicine criteria of sequela of pelvic inflammatory disease and the standards of TCM syndrome of pelvic inflammatory disease of accumulated damp heat according to traditional Chinese medicine.

排除标准

  • 1. Patients with severe diseases of heart, liver, kidney and hematopoietic system;
  • 2. Women in pregnancy or to be pregnant in near future or in lactation period;
  • 3. Women who are unable to cooperate, such as those with neurological or mental disorders, or unwilling to cooperate;
  • 4. Those with allergic constitution or multiple drug allergy;
  • 5. Those who have recently used similar drugs for treatment, such as taking drugs with related or antagonistic effects, resulting in difficulty in judging the efficacy of the drugs.

研究者

发起方
Xianyang Central Hospital

相似试验